BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20240329T084959Z
UID:ae68d700-1998-4a89-bda3-5a7efc350bf9
DTSTART:20201210T080000
DTEND:20201211T080000
CLASS:PRIVATE
DESCRIPTION:
\nWith 17+ hours of content\, we will be tackling the key issues
from the benchside to commercialization. By considering a range of therape
utic areas\, the conference is designed exclusively for the Cannabinoid dr
ug developer. Our speakers will discuss complex Cannabinoid pharmacology\,
formulations\, clinical trials\, patient education and commercial challen
ges.
\n
\nURL:
\nTickets: https://go.evvnt.com/267417-0?pid=1052
\n
\nPrices:
\nConference Only: GBP 1999
.0\,
\nConference + 2 Workshops: GBP 2897.0
\n
\nSp
eakers: Chris Bunka\, Chairman of the Board and Chief Executive O
fficer\, Lexaria Biosciences\, Tamá\;s Biro\, Professor\, Research C
enter for Molecular Medicine Departments of Immunology and Physiology\, Un
iversity of Debrecen\, Le Roy Dowey\, Head of Corporate Development\, Gree
nlight Medicines\, Vincenzo di Marzo\, Canada Excellence Research Chair\,
Université\; Laval and Research Director\, CNR\, Sazzad Hossain\, CE
O Entourage Biosciences / CSO\, Inmed Pharmaceuticals Inc\, Allyn Howlett\
, Professor\, Wake Forest University\, Gary Hiller\, Chief Operations Offi
cer and President\, Phytecs\, Catherine Jacobson\, Director of Clinical Re
search\, Tilray\, Zohar Koren\, Chief Executive Officer and Founder\, SciC
ann\, Shimon Lecht\, Chief of Research and Development  \;CannRx\, Arn
old Lippa\, Executive Chairman and Chief Scientific Officer\, RespireRx Ph
armaceuticals\, Jeff Eliot Margolis\, Senior Vice President\, Chief Financ
ial Officer\, Treasurer\, Secretary\, member of the Board of Directors\, R
espireRx Pharmaceuticals\, Soumyajit Majumdar\, Professor of Pharmaceutics
and Drug Delivery\, University of Mississippi\, Brian Murphy\, Chief Exec
utive Officer and Chief Medical Officer\, Nemus Bioscience\, Inc\, Richard
Purcell\, Senior Vive President\, RespireRx\, Dan Peer\, Chair\, Tel Aviv
University Cancer Biology Research Center\; Managing Director\, Center fo
r Translational Medicine\, Jutta Roth\, Chief Scientific Officer\, Oxford
Cannabinoid Technologies\, Andrea Small- Howard\, Chief Scientific Officer
\, GB Sciences\, Adi Zulloff-Shani\, Chief Technology Officer\, Therapix\n
\nCategory: Conferences\, Science\, Health an
d Medicine\, Pharmaceuticals\, Drug Development
SUMMARY:International Cannabinoid Derived Pharmaceuticals Summit
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-PT1H
SUMMARY:International Cannabinoid Derived Pharmaceuticals Summit
END:VALARM
END:VEVENT
END:VCALENDAR